Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod-Reference-Cited by-同舟云学术

Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod

Published:2016-02-09 Issue:7 Volume:22 Page:969-971
ISSN:1352-4585
Container-title:Multiple Sclerosis Journal
language:en
Short-container-title:Mult Scler

Author:

Behle Valeria¹,Wobser Marion¹,Goebeler Matthias¹,Stoevesandt Johanna¹

Affiliation:

1. Department of Dermatology, Venerology and Allergology, University Hospital of Würzburg, Würzburg, Germany

Abstract

Fingolimod-related viral infections have been described on several occasions since its introduction in 2010. We hereby add a report on an otherwise immunocompetent, 18-year old Caucasian man with relapsing-remitting multiple sclerosis who developed a protracted and extensive molluscum contagiosum (MC) virus infection shortly after being started on fingolimod. Wide-spread cutaneous MC infections in adult patients are considered indicative of underlying immunosuppression. Neurologists prescribing fingolimod ought to be aware of a possibly increased risk of MC, but also need to know about its relative benignity, lack of extra-cutaneous complications, and adequate treatment options.

Publisher

SAGE Publications

Subject

Clinical Neurology,Neurology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1352458516629560

Reference7 articles.

1. Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

2. Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

3. Reactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis

4. Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod

5. T-cell response against varicella-zoster virus in fingolimod-treated MS patients

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical molluscum contagiosum on multiple sclerosis patients treated with fingolimod: A case report;Clinical Case Reports;2022-10

2. Sphingosine-1 Phosphate Receptor Modulators;Infectious Complications in Biologic and Targeted Therapies;2022

3. Molluscum contagiosum in the setting of Fingolimod: The experience at one institution;Multiple Sclerosis and Related Disorders;2021-11

4. Disseminated molluscum contagiosum associated with immunomodulatory therapy;JAAD Case Reports;2020-08

5. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors);Clinical Microbiology and Infection;2018-06